(ShareCast News) - Shares in Synergy Health rocketed on Friday after it announced that a federal court in Ohio has ruled against the Federal Trade Commission's request for a preliminary injunction to block Steris' $1.9bn acquisition of the group."We are pleased that the Court has agreed with our position and we will be working to close the transaction with Steris Corporation as quickly as possible," said chief executive officer Dr Richard Steeves."We believe that this is a strategically sensible deal that is beneficial to our customers, employees and our shareholders, creating new opportunities for growth with our combined strengths".In May, the Federal Trade Commission filed a lawsuit to stop the deal, saying it would both companies' customers by reducing competition between them based on innovative sterilisation techniques. "There is really very little conditionality left now - all that needs to be done to close this deal is the approvals of both sets of shareholders, who vote on Friday 2 October," said Olivetree Securities. "Expect to see Synergy trading as if this is realistically a done deal now," it added.At 0857 BST, Synergy shares were up 44% at 2,265p.